October 14, 2004

Skinvisible Presents Patened Polymer Technology at Dermatology Update in Vancouver Canada

LAS VEGAS, Oct 14, 2004 (Canada NewsWire via COMTEX) --

Skinvisible, Inc. (OTC Bulletin Board: SKVI) (Website: www.skinvisible.com) announces through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc. that it will present its recently patented polymer delivery technology, "Invisicare(R)" in a poster presentation at the 20th Annual Dermatology Update Conference (www.dermatologyupdate.com) at the Westin Bayshore Resort & Marina in Vancouver British Columbia on Oct. 15 & 16. The company was granted United States Patent 6,756,059 for "Topical Composition, Topical Composition Precursor, and Methods For Manufacturing And Using" on June 29, 2004.

The patent is directed at manufacturing topical polymer-based delivery system compositions and includes disclosure of various "Topical Compositions and Methods for Manufacturing and Using the Compositions." A divisional application is pending, directed at "Topical Composition and Methods for Using the Composition." The Company has registered the name "Invisicare(R)" to identify the fifteen different polymer compositions it has developed to date.

When topically applied, products incorporating "Invisicare(R)" adhere to the skin's outer layers forming a protective bond that resists both wash-off and perspiration for extended periods of time, while delivering targeted levels of active ingredients to the skin. Utilizing its technologies, the Company has developed and tested several dermatological formulations including antimicrobial hand sanitizers, sunscreens, anti-acne, anti-fungal, anti-eczema and anti-psoriatic products.

Dermatology Update has been the vehicle of choice for launching over 90% of all dermatological agents to be introduced to Canadian dermatologists since its inception in 1984.

Terry Howlett, the Companies President, states, "This is our first opportunity to present to the manufacturers of dermatology products the benefits that "Invisicare(R)" offers over the traditional delivery methods which usually include petrolatum, silicones and alcohol."

This annual event brings together the major opinion leaders consisting of 200 Canadian dermatologists, including academic; clinical based dermatologists as well as residents, thus providing an excellent cross section of users in clinical practice.

Headquartered in Las Vegas, Nevada, Skinvisible, Inc. is focused on the development of innovative topical polymer-based delivery systems and related technologies incorporating its patent-pending formula/process for combining hydrophilic and hydrophobic polymers into stable water emulsions. Skinvisible's(R) primary marketing and sales objectives are to license its technologies and/or sell its delivery systems to provide enhanced product performance for established brand manufacturers and providers of prescription, over-the-counter, cosmetic, and skincare products. In addition Skinvisible(R) formulates and manufactures products for private label customers.

This press release contains "forward looking" statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports that will be on file with the US Securities and Exchange Commission (including but not limited to the report on Form 10-KSB for the quarter ending June 30, 2004).

For Corp. Info. Contact: T. Howlett - Skinvisible, Inc. - Ph. (702) 433-7154 / Fax (702) 433-7192 / Email: terry@skinvisible.com For Media Info. Contact: Tommi Hanley - Thompson Lloyd Communications - Ph. (250) 860-9959 / Email: tommi.tlc@shaw.ca

Press Release Index

New Press Release Alerts:

If you are interested in receiving corporate and new product development news from Skinvisible, simply enter your email address below.